Drugs / HCP1302
last change Aug 2015 re-read 2 minutes ago

HCP1302

Developed for
erectile dysfunction · hypertensive disorder
Investigated by
Hanmi Pharmaceutical Company Limited

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02587988 Sep 2014 → May 2015 erectile dysfunction, hypertensive disorder Hanmi Pharmaceutical Company Limited Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HCP1302 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02587988